SIG: Real-World Evidence (RWE) Collaborative

Thank you to everyone who attended the RWE Collaborative SIG meeting, whether in person or online. Our SIG continues to thrive within the ISPE community, advancing our mission to promote global knowledge exchange on RWD and RWE regarding the use, benefits, ...

Hello Everyone, I am excited to share our latest paper, titled "Exploring the Scientific Underpinnings of Investigating Safety Signals: Analytical Insights in Deciphering Drug Safety Evidence," published in Frontiers in Drug Safety and Regulation ...

Good Afternoon, Our team at the FDA is recruiting a physician (must have a US medical license) to serve as a scientific and regulatory subject-matter expert for real-world evidence (RWE) analytics in the Immediate Office of the Office of Medical Policy ...

*** The same email has been sent through the RWE SIG mailing list* ********** Hello RWE Collaborative, Hope all is well! There are a lot of updates to share prior to our next meeting on May 24 th and appreciate in advance you ...

Dear ISPE Community, We are currently assessing the awareness and use of reporting checklists recommended for Non-Interventional Post-Authorization Safety studies (NI-PASS) or Post Marketing Requirement (PMR) studies. This research aims to ...